Scinai Immunotherapeutics Ltd (SCNI NASDAQ) stock market data APIs
$1.6381
-0.01(-0.6%)
as of September 15, 2025
Try our APIs with
free plan!
Scinai Immunotherapeutics Ltd Financial Data Overview
Price chart is built with
Anychart
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Prev. Close
1.6381
Open
1.627
High
1.643
Low
1.5713
52 wk Range
1.4-4.76
Market Cap
2 468 K
P/E Ratio
0.39
Shares Outstanding
1 514 K
Revenue
1 147 K
EPS
-5.69
Beta
1.836
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Scinai Immunotherapeutics Ltd data using free add-ons & libraries
Get Scinai Immunotherapeutics Ltd Fundamental Data
Scinai Immunotherapeutics Ltd Fundamental data includes:
- Net Revenue: 1 147 K
- EBITDA: -6 745 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Scinai Immunotherapeutics Ltd News
New
Here are the top movers in Wednesday's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TOP GAINERS TICKER CHANGE COMMENT MNTS [https://www.chartmill.com/s...
There are notable gap-ups and gap-downs in today's session.
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT ...
Stay updated with the stocks that are on the move in today's pre-market session.
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARK...
Scinai Immunotherapeutics reports Q1 results
* Scinai Immunotherapeutics press release [https://seekingalpha.com/pr/20121077-scinai-reports-q1-2025-financial-results-highlighting-strong-cdmo-revenue-momentum-and] (NASDAQ:SCNI [https://seekinga...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
